Xu Hanqing, He Yi, Chen Sheng, Meng Chen, Liu Qingyi, Huang Xiao-Jian, You Hong-Bo
Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan City, Hubei Province, China.
Department of Orthopedics, The Second Affiliated Hospital of Nanchang University, Nanchang, 1 Minde Road, Donghu, Nanchang 330006, Jiangxi, China.
Int Immunopharmacol. 2025 Feb 6;147:114027. doi: 10.1016/j.intimp.2025.114027. Epub 2025 Jan 12.
To study the effect of CCR1 and its ligands on macrophage polarization and evaluate its effect on chondrocytes in relieving the progression of osteoarthritis.
RAW cells were polarized to M1/M2 subtype, and then different concentrations of BX471 were added to selectively inhibit CCR1. The polarization of the cells was detected by RT-qPCR, immunofluorescence and flow cytometry. CCL5 and CCL7 genes were silenced by SiRNA and its role in macrophage polarization was analyzed. Macrophage conditioned medium was further used to stimulate chondrocytes. Histological observation was carried out on models of medial meniscus (DMM) with or without BX471 treatment.
We found that blocking of CCR1 and silencing of its ligand, CCL5 and CCL7, reduced the polarization of M1 macrophages. In terms of mechanism, we found that blocking CCR1 could reduce the activation of NF-κB pathway and inhibit the phosphorylation of IKK, IκBα and P65. In addition, blocking of CCR1 could also reduce cartilage injury induced by macrophage conditioned medium. In vivo, blocking of CCR1 reduced the infiltration and accumulation of M1 macrophages and alleviated articular cartilage injury.
CCL5/CCL7-CCR1 axis was involved in macrophage polarization, and blocking it could reduce synovitis and alleviate the process of OA.
研究CCR1及其配体对巨噬细胞极化的影响,并评估其对软骨细胞缓解骨关节炎进展的作用。
将RAW细胞极化为M1/M2亚型,然后加入不同浓度的BX471选择性抑制CCR1。通过RT-qPCR、免疫荧光和流式细胞术检测细胞的极化情况。用SiRNA沉默CCL5和CCL7基因,并分析其在巨噬细胞极化中的作用。进一步用巨噬细胞条件培养基刺激软骨细胞。对接受或未接受BX471治疗的内侧半月板(DMM)模型进行组织学观察。
我们发现阻断CCR1及其配体CCL5和CCL7的沉默可减少M1巨噬细胞的极化。在机制方面,我们发现阻断CCR1可降低NF-κB通路的激活并抑制IKK、IκBα和P65的磷酸化。此外,阻断CCR1还可减少巨噬细胞条件培养基诱导的软骨损伤。在体内,阻断CCR1可减少M1巨噬细胞的浸润和积聚,并减轻关节软骨损伤。
CCL5/CCL7-CCR1轴参与巨噬细胞极化,阻断该轴可减轻滑膜炎并缓解骨关节炎进程。